Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

44 trials with published results (13%)

Research Maturity

194 completed trials (58% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.3%

18 terminated out of 337 trials

Success Rate

91.5%

+5.0% vs benchmark

Late-Stage Pipeline

9%

30 trials in Phase 3/4

Results Transparency

23%

44 of 194 completed with results

Key Signals

44 with results92% success18 terminated

Data Visualizations

Phase Distribution

273Total
Not Applicable (209)
Early P 1 (2)
P 1 (7)
P 2 (25)
P 3 (18)
P 4 (12)

Trial Status

Completed194
Unknown58
Recruiting29
Terminated18
Withdrawn13
Active Not Recruiting10

Trial Success Rate

91.5%

Benchmark: 86.5%

Based on 194 completed trials

Clinical Trials (337)

Showing 20 of 20 trials
NCT06754046Not ApplicableRecruitingPrimary

BELIEVE Trial: Bulking vErsus sLing for Treating Stress Urinary IncontinEnce at the Time of Vaginal prolapsE Repair (BELIEVE)

NCT03913845Phase 4CompletedPrimary

The Impact of Retropubic Lidocaine vs Saline on Postoperative Urinary Retention Following Midurethral Sling

NCT06480227Not ApplicableRecruitingPrimary

Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence

NCT03671694Not ApplicableActive Not RecruitingPrimary

Laser Vaginal Treatment for SUI

NCT05952258Not ApplicableEnrolling By InvitationPrimary

Magnetic Stimulation as a Treatment for Stress Urinary Incontinence

NCT06161506Phase 2Recruiting

Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer

NCT04829357RecruitingPrimary

Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System

NCT04829994Active Not RecruitingPrimary

Post-Market Clinical Follow-Up onTVT EXACT® Continence System

NCT04829175RecruitingPrimary

Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry

NCT04586166Not ApplicableActive Not RecruitingPrimary

Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy

NCT07501065Phase 4Not Yet Recruiting

Prophylactic Antibiotics for Outpatient Urethral Bulking

NCT02785016CompletedPrimary

Surgical Management for Suburethral Slings

NCT06416982Not ApplicableActive Not Recruiting

Perineal Massage for Pessary Examinations

NCT05611970Not ApplicableTerminatedPrimary

Pippa Pessary Study (Clinical Trial)

NCT03104517Phase 3Active Not RecruitingPrimary

Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence

NCT07455838Not ApplicableNot Yet RecruitingPrimary

Impact of Virtual Reality Pelvic Floor Training on Postpartum Stress Urinary Incontinence

NCT07095283Not ApplicableCompletedPrimary

Second-generation Radiofrequency Application and Therapeutic Exercise for Stress Urinary Incontinence

NCT07387640Not ApplicableNot Yet Recruiting

Synchronized Core-Pelvic Floor Activation in Urinary Incontinence

NCT04984317Early Phase 1SuspendedPrimary

Feasibility of BOTOX Injection on Improving Female Stress Urinary Incontinence

NCT04088331CompletedPrimary

Artificial Urinary Sphincter Clinical Outcomes

Scroll to load more

Research Network

Activity Timeline